← Back
$LIXT All transactions

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

A

$ Value

$0

Shares

10,000

Price

$0

Filed

Jul 8

Insider

Name

Bernards Rene

Title

CIK

0001939159

Roles

Director

Transaction Details

Transaction Date

2025-06-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,000

Footnotes

Effective June 30, 2025, the reporting person was granted stock options to purchase an aggregate of 10,000 shares vesting in eight equal installments on the last day of each subsequent quarter until fully vested with vesting to start on September 30, 2025. | Effective June 30, 2025 the reporting person was granted stock options to purchase an aggregate of 10,662 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.

Filing Info

Accession No.

0001641172-25-018283

Form Type

4

Issuer CIK

0001335105

Bernards Rene's History

Date Ticker Type Value
2025-06-30 LIXT A $0
2025-06-30 LIXT A $0

Other Insiders at LIXT (90d)

Insider Bought Sold Last
Felix Lourdes 2026-04-15
Pursglove Geordan Garrett
CEO and Chairman of the Board
2026-04-15
Sawyer Jason David 2026-04-15
Holloway Michael Andrew 2026-04-15
Stazzone Peter
Chief Financial Officer
2026-04-15
Primus Guy Warren 2026-04-15